299 assets in Alzheimer Disease

Therapeutic assets addressing Alzheimer Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Immunoglobulin G4-Kappa, Anti-[Homo Sapiens Lgals3 (Galectin 3)], Humanized Monoclonal Antibody (Gamma4 Heavy Chain Humanized (1-442) [Vh (Homo Sapiens Ighv1-301 (88.7%) -(Ighd) -Ighj601 (93.3%), Cdr-Imgt [8.8.9] (26-33.51-58.97-105)) (1-116)-Homo Sapiens Ighg401, Ng4M(A) Ch2 L92, G4V5 H P10 (Ch1 (117-214), Hinge 1-12 S10>P (224)(215-226), Ch2 L92 (305) (227-336), Ch3 (337-441), Chs K2>Del (442)) (117-442)], (130-219')-Disulfide With Kappa Light Chain Humanized (1'-219') [V-Kappa(Homo Sapiens Igkv2D-2902 (89.0%) -Igkj201(100%), Cdr-Imgt [11.3.9] (27-37.55-57.94-102)) (1'-112') -Homo Sapiens Igkc01 (100%), Km3 A45.1(158), V101 (196) (113'-219')]; Dimer (222-222'':225-225'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Glycoform Alfa) Alzheimer Disease	TrueBinding, Inc.	P2	B (58)
Melatonin Alzheimer Disease	Saint Vincent's Hospital, Korea	P3	B (58)
Spironolactone Alzheimer Disease	Emory University	P4	B (58)
Suvorexant Alzheimer Disease	Washington University School of Medicine	P3	B (58)
Trans-Resveratrol Alzheimer Disease	Zaparackas and Knepper LTD	P2	B (58)
Vitamin D Alzheimer Disease	Rune Skovgaard Rasmussen	P3	B (58)
Abbv-552 Alzheimer Disease	AbbVie	P2	B (57)
Abbv-916 Alzheimer Disease	AbbVie	P2	B (57)
Allogeneic Msc Alzheimer Disease	Longeveron Inc.	P2	B (57)
Exv-801 Alzheimer Disease	Exciva GmbH	P2/3	B (57)
Exv-802 Alzheimer Disease	Exciva GmbH	P2/3	B (57)
Obicetrapib Alzheimer Disease	NewAmsterdam Pharma	P2	B (57)
Phenserine Alzheimer Disease	Helse Stavanger HF	P2/3	B (57)
Posiphen Alzheimer Disease	Annovis Bio Inc.	P2/3	B (57)
RG6289 Alzheimer Disease	Banner Health	P2/3	B (57)
Simufilam Alzheimer Disease	Cassava Sciences, Inc.	P3	B (57)
ar1001 Alzheimer Disease	AriBio Co., Ltd.	P3	B (56)
.Beta.-(1,4)-D-Oligomannurarate 971 Alzheimer Disease	First Affiliated Hospital Xi'an Jiaotong University	P4	B (56)
Caffeine Alzheimer Disease	University Hospital, Lille	P3	B (56)
Choline Alfoscerate Alzheimer Disease	Daewoong Bio Inc.	P4	B (56)
Enavermotide Alzheimer Disease	Samsung Pharmaceutical Co., Ltd.	P3	B (56)
Gabapentin Enacarbil Alzheimer Disease	University of Texas at Austin	P4	B (56)
Masitinib Alzheimer Disease	AB Science	P3	B (56)
Masupirdine Alzheimer Disease	Suven Life Sciences Limited	P3	B (56)
mlc901 Alzheimer Disease	Moleac Pte Ltd.	P3	B (56)
Rifaximin Alzheimer Disease	Jasmohan Bajaj	P2	B (56)
Rotigotine Alzheimer Disease	I.R.C.C.S. Fondazione Santa Lucia	P3	B (56)
Trospium Alzheimer Disease	Neurology Office of South Florida	P3	B (56)
Xanomeline Alzheimer Disease	Neurology Office of South Florida	P3	B (56)
Zunveyl® Alzheimer Disease	Alpha Cognition, Inc	P4	B (56)
Aadvac1 Alzheimer Disease	Paul S. Aisen	P2	CCC (55)
Aducanumab Alzheimer Disease	Biogen	P3	CCC (55)
Astrostem Alzheimer Disease	Nature Cell Co. Ltd.	P2	CCC (55)
ER-176 Alzheimer Disease	The Methodist Hospital Research Institute	P2	CCC (55)
Flavone, 3,3',4',5,7-Pentahydroxy- Alzheimer Disease	Zaparackas and Knepper LTD	P2	CCC (55)
Shr-1707 Alzheimer Disease	Atridia Pty Ltd.	P2	CCC (55)
al002 Alzheimer Disease	Alector Inc.	P2	CCC (54)
Dalzanemdor Alzheimer Disease	Supernus Pharmaceuticals, Inc.	P2	CCC (54)
Daoib Alzheimer Disease	Chang Gung Memorial Hospital	P2	CCC (54)
Dexasone Alzheimer Disease	Eli Lilly and Company	P3	CCC (54)
Leuporelin Alzheimer Disease	Weill Medical College of Cornell University	P2	CCC (54)
Nadravaleucel Alzheimer Disease	NKGen Biotech, Inc.	P2	CCC (54)
Nanolithium® Np03 Alzheimer Disease	Medesis Pharma SA	P2	CCC (54)
Sirolimus Alzheimer Disease	Karolinska Institutet	P2	CCC (54)
2-BUTENEDIOIC ACID, (2E)-, DIMETHYL ESTER Alzheimer Disease	Medical University of Lodz	P2	CCC (53)
acd856 Alzheimer Disease	AlzeCure Pharma	P1	CCC (53)
All-P-Ambo-2'-O-(2-Methoxyethyl)-5-Methyl-P-Thiocytidylyl-(3'?5')-2'-O-(2-Methoxyethyl)-5-Methylcytidylyl-(3'?5')-2'-O-(2-Methoxyethyl)-P-Thioguanylyl-(3'?5')-2'-O-(2-Methoxyethyl)-5-Methyl-P-Thiouridylyl-(3'?5')-2'-O-(2-Methoxyethyl)-5-Methyl-Pthiouridylyl-( 3'?5')-P-Thiothymidylyl-(3'?5')-P-Thiothymidylyl-(3'?5')-2'-Deoxy-5-Methyl-P-Thiocytidylyl-(3'?5')-Pthiothymidylyl-( 3'?5')-P-Thiothymidylyl-(3'?5')-2'-Deoxy-Pthioadenylyl-( 3'?5')-2'-Deoxy-5-Methyl-P-Thiocytidylyl-(3'?5')-2'-Deoxy-5-Methyl-P-Thiocytidylyl-(3'?5')-2'-O-(2-Methoxyethyl)-Pthioadenylyl-( 3'?5')-2'-O-(2-Methoxyethyl)-5-Methylcytidylyl-(3'?5')-2'-O-(2-Methoxyethyl)-5-Methyl-P-Thiocytidylyl-(3'?5')-2'-O-(2-Methoxyethyl)-5-Methyl-P-Thiocytidylyl-(3'?5')-2'-O-(2-Methoxyethyl)-5-Methyluridine Alzheimer Disease	Biogen	P2	CCC (53)
Cot Alzheimer Disease	Evon Medics LLC	P2	CCC (53)
Emapunil Alzheimer Disease	Imperial College London	P2	CCC (53)
Enrupatinib Alzheimer Disease	Elixiron Immunotherapeutics Inc.	P2	CCC (53)

Showing 51 to 100 of 299 assets

PreviousPage 2 of 6Next